Boehringer Ingelheim

J&J Sues Boehringer Unit Over Doxil Production Pact
Bloomberg
Fri, 09/13/13 - 08:32 am
JNJ
Boehringer Ingelheim
Doxil
Conflicting Data on Spiriva Safety
Med Page Today
Wed, 09/11/13 - 08:57 am
Spiriva
Boehringer Ingelheim
COPD
J&J Sues Boehringer Ingelheim Over Arbitration Dispute
Bloomberg
Tue, 09/10/13 - 10:21 am
JNJ
Boehringer Ingelheim
Boehringer targets sales reps in new round of French job cuts
Fierce Pharma
Mon, 09/9/13 - 10:25 am
Boehringer Ingelheim
layoffs
France
Disappointing Results with Boehringer's Pradaxa for Mechanical Valves
Forbes
Tue, 09/3/13 - 09:28 am
Pradaxa
mechanical valves
Boehringer Ingelheim
dabigatran
Boehringer sales flat as world pharma market 'stagnates'
Pharma Times, UK
Thu, 08/15/13 - 10:46 am
Boehringer Ingelheim
earnings
First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for TRADJENTA® (linagliptin) Tablets in Type 2 Diabetes
Yahoo/PR Newswire
Wed, 07/31/13 - 09:11 am
Tradjenta
diabetes
type 2 diabetes
Boehringer Ingelheim
Eli Lilly
3 Potential Game Changers for COPD
Motley Fool
Wed, 07/17/13 - 10:59 am
COPD
Anoro
GSK
Theravance
QVA149
Novartis
olodaterol
Boehringer Ingelheim
Pfizer
FDA approves GILOTRIF™ (afatinib) as first-line treatment for metastatic non-small cell lung cancer with common EGFR mutations
Sacramento Bee, CA
Sat, 07/13/13 - 12:37 pm
non-small cell lung cancer
Gilotrif
Afatinib
Boehringer Ingelheim
Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product
Yahoo
Mon, 07/8/13 - 09:43 am
diabetes
Eli Lilly
Boehringer Ingelheim
Europe
LY2963016
long-acting insulin
biosimilars
Bayer rival Boehringer seeks wider use of anti-clotting pill
Reuters
Mon, 06/24/13 - 10:31 am
Bayer
Boehringer Ingelheim
anticoagulants
Pradaxa
deep vein thrombosis
pulmonary embolism
Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with type 2 diabetes
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:20 am
empagliflozin
type 2 diabetes
diabetes
Boehringer Ingelheim
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
Boehringer to build biopharma facility in China
Pharma Times, UK
Fri, 06/7/13 - 09:45 am
China
Boehringer Ingelheim
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer
Forbes
Thu, 05/23/13 - 10:44 am
JNJ
Medivation
Boehringer Ingelheim
Pfizer
Bristol-Myers Squibb
Xarelto
Zytiga
A Boehringer Shake Up And An FDA Warning Letter Over Production Gaffes
Pharmalot
Wed, 05/22/13 - 10:19 am
FDA
warnings
Boehringer Ingelheim
drug manufacturing
Boehringer anti-clotting pill gains blockbuster status
Reuters
Wed, 04/24/13 - 08:47 am
anticoagulants
Boehringer Ingelheim
Pradaxa
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Pharmalot
Thu, 04/18/13 - 10:43 am
adverse events
diabetes
FDA
Novo Nordisk
Bristol-Myers Squibb
Boehringer Ingelheim
Merck
Eli Lilly
Boehringer Ingelheim fuels gene therapy startup focused on eye diseases
Fierce Biotech
Fri, 04/12/13 - 01:49 pm
Boehringer Ingelheim
gene therapy
Eyevensys
Boehringer Ingelheim Venture Fund

Pages